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What is the central question of this study? 
 
We assessed the utility of a novel metric for quantifying ventilatory acclimatization to high altitude, 
derived from differential ascent and descent steady-state cardiorespiratory variables (i.e., 
hysteresis). Furthermore, we aimed to investigate whether the magnitude of cardiorespiratory 
hysteresis was associated with the development of acute mountain sickness.  
 
What is the main finding and its importance? 
Hysteresis in steady-state cardiorespiratory variables quantifies ventilatory acclimatization to high 
altitude. The magnitude of cardiorespiratory hysteresis during ascent to and descent from high 
altitude was significantly related to the development of acute mountain sickness symptoms. 
Hysteresis in steady-state chemoreflex drive can provide a simple, non-invasive method of tracking 
ventilatory acclimatization to high altitude.  
 
Abstract 
Maintenance of arterial blood gases is achieved through sophisticate d regulation of ventilation, 
mediated by central and peripheral chemoreflexes. Respiratory chemoreflexes are important during 
exposure to high altitude due to the competing influence of hypoxia and hypoxic hyperventilation-
mediated hypocapnia on steady-state ventilatory drive. Inter-individual variability exists in 
ventilatory acclimatization to high altitude, potentially affecting the development of acute mountain 
sickness (AMS). We aimed to quantify ventilatory acclimatization to high altitude by comparing 
differential ascent and descent values (i.e. hysteresis) in steady-state cardiorespiratory variables. We 
hypothesized that (a) the hysteresis area formed by cardiorespiratory variables during ascent and 
descent would quantify the magnitude of ventilatory acclimatization, and (b) larger hysteresis areas 
would be associated with lower AMS symptom scores during ascent. In 25 healthy, Diamox-free 
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pressure of end-tidal (PET)CO2, peripheral oxygen saturation (SpO2), minute ventilation (  E), 
chemoreceptor stimulus index (SI; PETCO2/SpO2) and the calculated steady-state chemoreflex drive 
(SS-CD;   E/SI) using portable devices (capnograph, peripheral pulse oximeter and respirometer, 
respectively). AMS symptoms were assessed daily using the Lake Louise Questionnaire. We found 
that (a) ascent-descent hysteresis was present in all cardiorespiratory variables, (b) SS-CD is a valid 
metric for tracking ventilatory acclimatization to high altitude and (c) highest AMS scores during 
ascent were significantly, moderately and inversely-correlated to SS-CD hysteresis magnitude (rs=-
0.408, P=0.043). We propose that ascent-descent hysteresis is a novel and feasible way to quantify 
ventilatory acclimatization in trekkers during high altitude exposure.  
 




Chemoreceptors and Ventilatory Acclimatization 
 Arterial blood gases (PaO2 and PaCO2) are maintained via two interacting respiratory 
chemoreflex loops, which communicate to regulate ventilation (Boulet et al., 2016; Bruce et al., 
2018; Pfoh et al., 2016). Central chemoreceptors (CCRs), located across several regions of the 
brainstem, hypothalamus and midbrain (Duffin, 2010; Nattie & Li, 2012), regulate ventilation in 
response to changes in CO2 and/or [H
+] within brain tissue (Duffin, 2010; Pfoh et al., 2016; Natte & 
Li, 2012; Guyenet et al., 2010; Skow et al., 2014). In contrast, peripheral chemoreceptors (PCRs), 
located within the aortic and carotid bodies, regulate ventilation in response to changes in PaO2, 
PaCO2 and pH (Pfoh et al., 2016; López-Barneo et al., 2016). Both CCRs and PCRs regulate ventilation 
via afferent signaling to the respiratory control centers in the brainstem, which modulate ventilation 
accordingly. Both central and peripheral chemoreflexes are important in the context of high altitude 
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Ventilatory acclimatization to hypoxia (VAH) can be described as the time-dependent increase in 
ventilation following chronic (days to weeks) exposure to hypoxia (Powell et al., 2000a). Typically, 
the assessment of ventilatory acclimatization is performed by determination of the hypoxic 
ventilatory response (HVR) (Pfoh et al., 2016 and 2017; Bruce et al., 2018; Steinback and Poulin, 
2007; Teppema and Dahan, 2010).  
Assessment of Chemoreflexes 
The mode of assessment of respiratory chemoreflexes is dependent on the experimental 
question, experimental design and to some extent, feasibility within the context. Lab-based 
assessments are performed through bespoke gas challenges specific to chemoreflex responses 
under investigation (Duffin, 2007). For example, assessment of the central chemoreflex can be 
performed by incremental or progressive increases in CO2 (hypercapnia) against a background of 
hyperoxia (Boulet et al., 2016; Duffin, 2011; Skow et al., 2014). The ventilatory response to steady-
state increases in CO2 is a result of augmented CCR activity, and the hyperoxia serves to dampen or 
silence PCR activity. In contrast, the peripheral chemoreflex can be elicited either through transient 
or steady-state gas challenges used to elicit acute and/or prolonged fluctuations in either PaO2 
and/or PaCO2 (Pfoh et al., 2016; Koehle et al., 2009; Girard et al., 1959; Chua & Coats, 1995) . Both 
steady-state and transient assessments of the peripheral chemoreflex are accompanied with several 
confounders which warrant consideration. Steady-state techniques are contaminated by: (a) 
autonomic, cerebrovascular and cardiovascular responses to chronic or prolonged hypoxia which 
may affect ventilation (Hoiland et al., 2015, Steinback & Poulin, 2007 and 2008), (b) high inter-
subject variability and repeatability, calling into question their validity (Pfoh et al., 2016) and (c) the 
possibility of CCR and PCR interaction (Wilson and Teppema, 2016). In contrast, transient tests of 
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response magnitudes equivalent to steady-state assessments (Pfoh et al., 2016; Teppema & Dahan, 
2010). In short, the method of chemoreflex assessment should be specific to the experimental 
question under investigation, but isolating central or peripheral chemoreflexes in humans is 
challenging and likely confounded, particularly in fieldwork contexts.  
Caveats of Chemoreflex Assessment during High Altitude Exposure 
Although lab-based techniques are heavily utilized for chemoreflex assessment, several 
issues arise when implementing these techniques in field-based studies, such as high altitude 
expeditions. Primarily, lab-based assessments of chemoreflexes typically involve the use of 
sophisticated and expensive equipment such as end-tidal forcing systems, gas analyzers and 
calibration gas tanks (Koehle et al., 2009; Steinback and Poulin, 2007; Tymko et al., 2015). In certain 
circumstances, it may not always be feasible or wise for the transportation of such bespoke 
equipment during high altitude expeditions due to high transport costs as well as risk of damage. In 
addition, the process of eliciting a hypoxic stressor in an environment where participants are already 
hypoxic could prove both uncomfortable and potentially dangerous for participants. Typically, the 
process of measuring chemoreflexes is by identifying the peak ventilatory response to a given 
stimulus. Previous literature has examined the ventilatory response to both isocapnic and 
poikilocapnic hypoxia (Steinbeck & Poulin, 2007), the latter being representative of the environment 
at altitude. The results showed a blunted peak ventilatory response during poikilocapnic hypoxia 
compared with isocapnic hypoxia, due to the HVR-mediated hypocapnia and the known CO2-O2 
stimulus interaction at the carotid body (Lahiri and DeLaney, 1975). Of note, after twenty minutes of 
exposure to poikilocapnic hypoxia, ventilation returns to near baseline (Steinback and Poulin, 2007). 
Exposure to high altitude incurs HVR-induced hypocapnia and resultant respiratory alkalosis. This 
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excretion by the renal system (Dempsey et al., 2014; Goldfarb-Rumyantzev & Alper, 2014; Krapf et 
al., 1991). This reduction in buffering capacity could also increase CCR sensitivity to alterations in CO2 
(Bruce et al., 2018; Forster et al., 1971). The acid-base and CO2 changes associated with exposure to 
altitude likely alter basal CCR and PCR chemoreceptor activity, thus making it difficult to compare 
chemoreflex response magnitude at altitude with unacclimated sea-level measures. 
 
 
Proposal of a Novel Steady-State Chemoreflex Drive Metric 
To combat the caveats of traditional lab-based assessments of chemoreflexes at altitude, 
our group proposes the utility of a novel metric termed steady-state chemoreflex drive (SS-CD). SS-
CD can serve as an alternative to traditional lab-based assessments of PCR and CCR chemoreflexes 
by providing a feasible, portable and relatively inexpensive method of quantifying VAH by measuring 
specific steady-state cardiorespiratory parameters. In addition, unlike peak chemoreflex tests, the 
measurement of steady-state cardiorespiratory parameters is likely a better representation of the 
ventilatory acclimatization status of a participant for a given combination of prevailing O2, CO2 and 
pH stimuli whilst at altitude (Bruce et al., 2018). SS-CD can be quantified by the measurement of 
steady-state end-tidal CO2 (PETCO2), peripheral oxygen saturation (SpO2) and minute ventilation (  E). 
Both PETCO2 and SpO2 are used to derive a stimulus index (SI: PETCO2/ SpO2; Bruce et al., 2018; Pfoh 
et al., 2017). SS-CD is then quantified by indexing   E against SI (  E/SI; Bruce et al., 2018; Pfoh et al., 
2017). Both PETCO2 and SpO2 are utilized to calculate SI as these metrics are positively and inversely 
linearly related to ventilation, respectively (Duffin, 2011; Rebuck & Campbell, 1974). In addition, SS-
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steady-state ventilation, to provide a comprehensive observation of the effects of both CCR and PCR 
activity on ventilation in the resting steady-state at altitude.  
 Aims and Hypotheses 
The aim of this study was to (a) assess the utility of SS-CD to characterize and quantify 
ventilatory acclimatization to hypoxia in the context of ascent to and descent from high altitude (i.e., 
hysteresis) and (b) assess whether SS-CD hysteresis magnitude during ascent was associated with 
the development of acute mountain sickness (AMS). We hypothesized that SS-CD ascent-descent 
hysteresis provides a feasible and portable metric for quantifying VAH at high altitude. Secondly, we 
reasoned that the magnitude of VAH at high altitude will be inversely related to the development of 





This study abided by the Canadian Government Tri -Council policy on research ethics with 
human participants (TCPS2) and the Declaration of Helsinki , except for registration in a public 
database. Ethical approval was received in advance through Mount Royal University Human 
Research Ethics Board (Protocol 100012) and the Nepal Health Research Council (Protocol 109-
2017). All participants were recruited via verbal communication and provided written and informed 
consent prior to voluntary participation in the study. This study took place in the context of a large 
research and field-course expedition to high altitude in the Nepal Himalaya. However, the specific 
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Participant Recruitment and Inclusion Criteria 
Twenty-nine healthy participants (14 females) were recruited as part of a research 
expedition to Everest base camp, Nepal Himalaya. The research expedition involved a slow, 
incremental ascent/descent profile to 5160m over a period of 18 days (see Figure 1). Participants 
were non-smokers and had no pre-existing cardiovascular, pulmonary, neurological or 
cerebrovascular medical conditions. Furthermore, in order to be included for analysis in this study, 
participants had to complete the entire research expedition without the aid of acetazolamide  
(Diamox). Acetazolamide is a pharmaceutical agent commonly prescribed for high altitude exposure, 
acting to increase ventilation through renal carbonic anhydrase blockade (Leaf & Goldfarb, 2007; 
Low et al., 2012; Luks et al., 2012). Data collection was completed at rest prior to breakfast each 
morning (06:00-09:00) on non-trekking days. Female ovarian status was not accounted for due to 
the nature of fieldwork expeditions. All participants lived below 1400m and were non-acclimatized 
prior to ascent, and each participant spent a total of three days at Kathmandu (1400m) before 
ascent began.  
Instrumentation and Data Collection 
Participants were instrumented for resting, steady-state measurements in a lodge between 
06:00-09:00 after at least one night at each altitude: 1400m (day 0), 3440m (ascent; day 3), 4240m 
(ascent; day 7), 5160m (ascent; day 10), 4240m (descent, day 12), 3440m (descent; day 15) and 
again at 1400m (day 18). Data was collected in the seated position, and participants were provided 
with a personal mouthpiece and nose clip for the duration of the expedition. Participants were 
provided with noise cancelling headphones and asked to close their eyes during data recording. 
Participants were instrumented with a portable capnograph (Masimo EMMA, Danderyd, Sweden) for 
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(Masimo Pronto; Switzerland) on their left middle finger for measurement of SpO2 (%) and a 
respirometer (nSpire, Haloscale respirometer, USA   or en  la  on    E; L/min). Once instrumentation 
was complete, the participants were instructed to close their eyes and after approximately three 
minutes, their values were recorded and archived. Recording of participants’ sel -reported AMS 
scores were incorporated in the daily measurements. AMS was quantified using the Lake Louise 
scoring system during ascent and descent (LLS; Roach et al., 1993). All participants followed the 
same trekking profile (Figure 1) and data collection protocol throughout the expedition. 
 
Data and Statistical analysis 
The daily ascent and descent cardiorespiratory variables (SpO2, PETCO2 and   E) were plotted 
using Graphpad prism 8 software. Statistical analysis was performed using SPSS v.26 statistical 
software. Stimulus index (SI) was derived through mathematical modelling of the recorded steady-
state cardiorespiratory variables (SI: PETCO2/SpO2). Steady-state chemoreflex drive (SS-CD) was then 
determined by indexing steady-state ventilation    E) against SI (SS-CD =   E/SI). Hysteresis areas were 
calculated using SigmaPlot software (Systat, v14). The area between the curves was calculated using 
definite integrals, the upper and lower limits (x-axis) being the lowest and highest altitudes reached 
during the trek (1400m and 5160m). Hysteresis area for SS-CD was dichotomized using a median 
split, with values below the median representing low responders and values above the median 
representing high responders, with the median value discarded. AMS positive (+) and AMS negative 
(-) participants were dichotomized by separating into two groups, with AMS+ defined as LLS of 3 or 
higher and AMS- defined as LLS of 0-2. 
Prior to statistical analysis, normal distribution was assessed using the Shapiro-Wilk test. In 
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If data did not violate the assumption of normal distribution, a repeated measures ANOVA was used 
for between-location analysis of variables. If data violated the assumption of normal distribution, a 
Friedman ranks test was performed. Following the Friedman ranks test, a Wilcoxon-rank test was 
used for post-hoc analysis of between-location differences in variables. Manual Bonferroni 
adjustments were made for multiple comparisons during the Wilcoxon-rank test. The level of 
statistical significance was divided by the number of multiple comparisons made to mitigate the risk 
of a type 1 error. In this instance, 21 comparisons were made between locations; therefore, our 
adjusted p-value was 0.05/21 = 0.002. Under normally distributed data statistical significance was 
set at p<0.05. As per journal guidelines, non-parametric data was presented as median with 
interquartile range (25th – 75th percentile), whereas normally distributed data are presented as mean 
± standard deviation. High vs. low responders, relative to SS-CD ascent-descent hysteresis area, were 
compared using an independent samples t-test (two-tailed). The SS-CD ascent-descent hysteresis 
area was compared between AMS (+) and AMS (-) participants using an independent samples t-test 
(two-tailed). The SS-CD hysteresis area was correlated with AMS scores (highest score in each 
participant) using a Spearman Rho correlation. Lastly, as data for AMS is presented on an ordinal 





Of the initial 29 participants recruited for this expedition, four were excluded from final 
analysis. Two participants took Diamox at 5160m (day 9) due to AMS symptoms (but completed the 
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severe AMS symptoms, and one participant was evacuated by helicopter during the descent due to 
an ankle injury. Twenty-five participants, all of whom completed an identical trekking ascent-descent 
profile and remained Diamox-free, were included in the final analysis (27.2±11.2 years; BMI 22.9±2.8 
kg/m2; 10 females). 
Cardiorespiratory Parameters 
End-tidal CO2 
Non-parametric Friedman ranks test was performed to assess for between-location 
differences in end-tidal CO2. There was a statistically significant interaction between location and 
end-tidal CO2, χ2 (6) = 116.34, p<0.001. A Wilcoxon signed-rank test was used for further post-hoc 
comparisons between locations (see Figure 2A). End-tidal CO2 was significantly reduced from 
baseline (1400m) at 3440m (ascent; day 3), 4240m (ascent; day 7), 5160m (ascent; day 10), 4240m 
(descent, day 12) and 3440m (descent; day 15) (median (IQR range): 31 (29-33) vs. 24 (23-27), 23 
(20-24), 21 (20-22) and 22 (20-24), respectively; Torr, p<0.001). There was no statistical difference 
between baseline (1400m) and 1400m (descent day 18) (median (IQR range) 31 (29-33) vs. 30 (28-
31), Torr, p=0.054).  
SpO2 
  Non-parametric Friedman ranks test was performed to assess for between-location 
differences in SpO2. There was a statistically significant interaction between location and SpO2, χ2 6  
= 129.38, p<0.001. A Wilcoxon signed-rank test was used for further post-hoc comparisons between 
locations (see Figure 2C). SpO2 was significantly reduced from baseline (1400m) at 3440m (ascent; 
day 3), 4240m (ascent; day 7), 5160m (ascent; day 10), 4240m (descent, day 12) and 3440m 
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94 (93-95), respectively; %, p<0.001). There was no statistical difference between baseline (1400m) 
and 1400m (descent day 18) (median (IQR range)), 97 (96-98) vs. 97 (96-98), %, p=0.674). 
Minute Ventilation    E) 
Non-parametric Friedman ranks test was performed to assess for between-location 
differences in   E. There was a statistically significant interaction between location and   E, χ2 6  = 
48.394, p<0.001. A Wilcoxon signed-rank test was used for further post-hoc comparisons between 
locations (see Figure 2E).  E was significantly increased from baseline (1400m) at 5160m (ascent; day 
10), 4240m (descent, day 12) and 3440m (descent; day 15) only (median (IQR range): 9.2 (7.3-10.7) 
vs. 10.9 (9.4-13.2), 11.6 (9.8-13.1), 11.8 (9.8-13.5), respectively; L/min, p<0.001). There was no 
statistical difference between baseline (1400m) and 1400m (descent day 18) (median (IQR range), 
9.2 (7.3-10.7) vs. 9.9 (7.5-11.4), L/min, p=0.242). 
 
Stimulus index (SI)  
Da a was normally d s r bu ed and d d no    ola e Mauchly’s  test of sphericity. A repeated 
measures ANOVA demonstrated a statistically significant interaction between location and stimulus 
index (SI) F(6,144) = 59.19, p<0.001, Np
2 = 0.71. Post-hoc analysis was performed to test for further 
significant differences between locations (see Figure 3A). SI was significantly reduced from baseline 
(1400m) to 3440m (ascent; day 3), 4240m (ascent; day 7), 5160m (ascent; day 10), 4240m (descent, 
day 12) and 3440m (descent; day 15) (mean ± SD: 0.32 ± 0.03 vs. 0.26 ± 0.03, 0.25 ± 0.03, 0.26 ± 
0.03, 0.22 ± 0.02, 0.23 ± 0.02 respectively, p<0.001). There was no statistical difference between 
baseline (1400m) and 1400m (descent day 18) (mean ± SD: 0.32 ± 0.03 vs. 0.31 ± 0.02, p=0.674). 
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Non-parametric Friedman ranks test was performed to assess for between-location 
differences in SS-CD. There was a statistically significant interaction between location and SS-CD, 
χ2 6  = 87.857, p<0.001. A W lcoxon s gned-rank test was used for further post-hoc comparisons 
between locations (see Figure 3C). SS-CD was significantly increased from baseline (1400m) at 
3440m (ascent; day 3), 4240m (ascent; day 7), 5160m (ascent; day 10), 4240m (descent, day 12) and 
3440m (descent; day 15) (median (IQR range): 28.03 (21.5-33.7) vs. 36.4 (27.6-44.8), 39.9 (29.5-
51.9), 45.4 (35.4-51.5), 50.3 (43.5-68.8), 49.3 (44.3-56.6) respectively; p<0.001). There was no 
statistical difference between baseline (1400m) and 1400m (descent day 18) (median (IQR range), 
28.0 (21.5-33.7) vs. 34.3 (23.3-39.4), p=0.093). 
SS-CD Ascent-Descent Hysteresis 
A non-parametric Mann Whitney-U test was performed to compare the highest self-
reported AMS score between high and low responders (see Figure 4D). A statistically significant 
difference was found for the highest self-reported AMS score and group (U = 37.5, p = 0.04). SS-CD 
ascent-descent hysteresis area was compared between high and low responders (see Figure 4C). An 
independent samples t-test was performed to compare SS-CD ascent-descent hysteresis in both 
groups. A statistically significant difference was found for SS-CD ascent-descent hysteresis area in 
high vs. low responders (mean ± SD: 48883 ± 13061 vs. 16060 ± 8128, a.u., t(22) = 7.39, p<0.001).  
SS-CD and Acute Mountain Sickness (AMS) 
SS-CD ascent-descent hysteresis area in AMS (+) vs. AMS (-) 
An independent samples t-test was used to compare SS-CD ascent-descent hysteresis area in 
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hysteresis area in AMS (+) vs. AMS (-) participants (mean ± SD; 23985 ± 16861 vs. 39652 ± 19921, 
a.u., t(22) = -2.057, p=0.052, see Figure 5A). 
SS-CD ascent-descent hysteresis area and AMS correlation 
A Spearman rho correlation found a moderate inverse relationship between SS-CD ascent-
descent hysteresis area and self-reported AMS, which was statistically significant (rs(23) = -0.408, p = 
0.043, see Figure 5B). 
DISCUSSION 
Primary Outcomes and Key Findings 
We aimed to assess the utility of a novel metric, ascent-descent hysteresis in SS-CD, to 
quantify ventilatory acclimatization in the context of incremental ascent to and descent from high 
altitude (5160m) in the Nepal Himalaya. The main findings of this study are (a) SS-CD hysteresis 
appears to be useful for tracking ventilatory acclimatization during high altitude ascent and descent 
and (b) SS-CD hysteresis magnitude is inversely related to the development of AMS symptoms. These 
findings suggest that ventilatory acclimatization can be quantified in the steady-state using simple 
and portable devices. Furthermore, these findings suggest a relationship between ventilatory 
acclimatization and the development of AMS during incremental ascent to high altitude. 
Cardiorespiratory Changes at Altitude 
We observed several hallmark changes in cardiorespiratory variables during exposure to 
high altitude. Our findings demonstrate significant reductions in both end-tidal CO2 and SpO2 in 
conjunction with a significant increase in   E during ascent, which were reversed as expected with 
descent. The reductions observed in both end-tidal CO2 and SpO2 are similar to those observed 
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2018). The changes observed in the cardiorespiratory system during exposure to high altitude are a 
result of the HVR, in part. Initially, low PaO2 levels are detected by the peripheral chemoreceptors 
(Teppema and Dahan. 2010) with resultant increases in afferent signaling along the carotid sinus 
nerve to the respiratory control centers in the brainstem, causing an increase in ventilation 
(Teppema and Dahan, 2010; Gonzalez et al., 1994). There is also evidence to support the existence 
of hypoxic sensitive central chemosensors, which contribute to the HVR (Angelova et al., 2015; 
Gourine and Funk, 2017; Powell et al., 2000b). Thus, it is likely that the increase in steady-state 
ventilatory drive observed during high altitude exposure is derived from both peripheral and central 
input with time-dependent changes in the key mechanisms involved (Pamenter & Powell, 2016) . 
Steady-State Chemoreflex Drive 
Our results offer strong support for the utility of SS-CD in quantifying VAH during high 
altitude exposure. As observed in Figure 3C, SS-CD increases incrementally during immediate ascent 
to altitude, returning to baseline levels following descent to 1400m. Of interest, we observed 
continued elevations in SS-CD at 3440m and 4240m during descent, compared with respective 
ascent values. This observation could be due in part to carotid body and central plasticity following 
acclimatization to chronic hypoxia (Dempsey et al., 2014). Numerous studies have demonstrated a 
heightened O2 sensitivity at the carotid body following chronic exposure to hypoxia (Barnard et al., 
1987; Nielsen et al., 1988; Vizek et al., 1987). This plasticity is not limited to the carotid body. Further 
evidence suggests central plasticity following chronic exposure to hypoxia (Dwinell and Powell, 
1999). Plasticity, or increased gain, within the central nervous system (CNS) is due to changes in 
integration of afferent signaling with resultant increases in ventilatory motor output (Powell, 2007; 




This article is protected by copyright. All rights reserved. 
 
contributes to the sustained elevation in SS-CD and ventilation observed at 3440m and 4240m 
during descent, compared with ascent values, following exposure to higher altitudes (5160m).  
AMS and Respiratory Chemoreflexes 
Several studies and reviews have attempted to determine the role of chemoreflexes and 
ventilatory acclimatization in the development of AMS through the simulation of high altitude 
environments, as well as comparing chemoreflex assessments at both sea-level and high altitude 
(e.g., Burtscher et al., 2008; Milledge et al., 1988; Smith et al., 2017; Grant et al., 2002). In general, 
the findings from these studies relating respiratory chemoreflexes and the development of AMS are 
inconsistent. Two conclusions can be drawn from these observations: (a) either there is no 
relationship between the development of AMS and chemoreflex acclimatization to altitude, or (b) 
the hitherto method of quantifying ventilatory acclimatization and chemoreflex es at altitude is 
inadequate. Our study suggests the latter. Due to the aforementioned concerns of utilizing lab-based 
assessments of chemoreflex at altitude (e.g., Bruce et al., 2018; Pfoh et al., 2016, 2017) we suggest 
our metric of SS-CD provides a more comprehensive analysis of the ventilatory strategy of 
individuals for a given O2, CO2 and acid-base status. Our results indicate a significant and inverse 
relationship in SS-CD hysteresis magnitude and the development of AMS symptoms, suggesting that 
greater ventilatory acclimatization to sustained hypoxia is associated with a moderately reduced 
susceptibility to AMS. From a physiological standpoint, larger SS-CD hysteresis magnitude could be a 
product of greater individual ventilatory sensitivity to hypoxia, resulting in more profound peripheral 
and central plasticity during chronic hypoxic exposure. The inverse relationship between SS-CD 
hysteresis magnitude and self-reported AMS could highlight the importance of VAH in preserving 
oxygenation and health during high altitude exposure. VAH could prove crucial for mitigating the 
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Methodological Considerations 
There are several limitations, which must be considered when interpreting these findings. 
Firstly, the requirement for both ascent as well as descent cardiorespiratory values in order to 
calculate SS-CD hysteresis calls into question the utility of this metric as a predictor variable for AMS 
in advance of an expedition. Ideally, simple physiological assessments and metrics, which can be 
performed either in a lab-setting at sea-level or progressively during ascent would have greater 
utility as a predictor variable for AMS. Unfortunately, such a metric or assessment has yet to be 
determined or developed. However, our findings suggest the importance of ventilatory 
acclimatization in preserving oxygenation and health during high altitude ascent, and our study 
advances a simple and portable technique for assessing ventilatory acclimatization in large groups of 
trekkers. In addition, our study provides normative values for SS-CD hysteresis for comparison for 
future trekkers and climbers as they ascend to and descend from similar altitudes.  
The acid-base status of our participants was not recorded during ascent-descent. However, 
in a previous study by our group incorporating an identical ascent profile we showed that arterial pH 
is remarkably stable during incremental ascent up to 5160m (Leacy et al., 2018; Zouboules et al., 
2018), suggesting adequate renal compensation during an 11-day incremental ascent model to 
5160m. Unlike traditional lab-based peak chemoreflex assessments, SS-CD does not provide 
independent assessment of peripheral and/or central chemoreflex gain. Instead, it provides an 
assessment of overall steady-state ventilatory drive considering a conjugate of both central and 
peripheral chemoreflexes and prevailing chemostimuli. We are not suggesting that SS-CD should 
replace traditional lab-based techniques used in peripheral or central chemoreflex assessments, 
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Lastly, the time-course of ascent and descent profiles was not uniform. Ascent from 1400m 
to 5160m was achieved over 11 days. In contrast, descent from 5160m to 1400m was achieved over 
9 days. How this might have affected cardiorespiratory hysteresis remains unclear. One could 
speculate that a longer descent profile would afford more time for both peripheral and central 
plasticity to chronic hypoxia. This could potentially increase the hysteresis area formed by 
cardiorespiratory variables. In any case, unlike ascent to high altitude, there are no guidelines 
regarding the descent from altitude, and a more rapid descent profile may have made our 
assessment impossible, given that we made measurements at identical altitudes during descent as 
during ascent (i.e., 3440m, 4240m).  
Conclusions 
In conclusion, our findings demonstrate a novel metric for the assessment of chemoreflex 
drive during incremental ascent to and descent from high altitude, namely calculation of ascent-
descent hysteresis magnitude of cardiorespiratory variables (SS-CD). The simplicity and portability of 
the SS-CD measurement illustrates the feasibility of its use in fieldwork contexts, thus providing 
utility to large research and/or commercial expeditions to high altitude. These findings provide 
valuable insight into the importance of ventilatory acclimatization in the protection against AMS 
symptoms. Future studies should examine the utility of this metric across various ascent profiles as 
well as prolonged exposure to altitude, where individuals spend extended periods at high altitudes 
before descending, where we anticipate that SS-CD hysteresis will be larger than the present study. 
Additionally, given the utility of carbonic anhydrase inhibitors during high altitude expeditions, and 
their effects on ventilation, it would be of interest to measure SS-CD hysteresis in participants 
receiving Diamox prophylaxis and/or treatment. Presumably, given that Diamox acts as a respiratory 
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Figure 1. Ascent-descent altitude trekking profile (date and altitude) of the expedition group. 
Measurements were made on participants every morning (~06:00-09:00) on indicated rest days 
during ascent and descent, including 1400m (day 0), 3440m (ascent, day 3), 4240m (ascent, day 7), 
5160m (ascent, day 10), 4240m (descent, day 12), 3440m (day 15), 1400m (day 18). Grey shaded 
circles indicate measurement days during ascent and white/clear circles indicate measurement days 
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Figure 2. Cardiorespiratory measures during ascent and descent, illustrating hysteresis.  Grey box 
and whiskers and circles (hysteresis) denote ascent. White/clear box and whisker and squares 
(hysteresis) denote descent. (A) Pressure of end-tidal (PET)CO2 (Torr) during ascent and descent. (B) 
PETCO2 hysteresis during ascent and descent. (C) Peripheral oxygen saturation (SpO2; %) during 
ascent and descent. (D) SpO2 hysteresis during ascent and descent. (E) Minute Ventilation (  E; L/min) 
during ascent and descent. (F)   E hysteresis during ascent and descent. All values are presented in 
box and whisker format. *** = P<0.001  rom 1400m. $ = P<0.05  rom 3440m. ∞ = P<0.05  rom 
4240m. % = P<0.05 from 5160m. @ = P<0.05 from 4240m (descent). £ = P<0.05 from 3440m 








Figure 3. Stimulus Index and steady state chemoreflex drive during ascent and descent, illustrating 
hysteresis. Grey box and whiskers and circles (hysteresis) denote ascent. White/clear box and 
whisker and squares (hysteresis) denote descent. (A) Stimulus index (PETCO2/SpO2) during ascent and 
descent. (B) SI hysteresis during ascent and descent. (C) Steady-state chemoreflex drive (SS-CD; 
  E/SI) during ascent and descent. (D) SS-CD hysteresis during ascent and descent. All values are 
presented in box and whisker. *** = P<0.001 from 1400m. $ = P<0.05 from 3440m. ∞ = P<0.05  rom 
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Figure 4. Dichotomization between high and low ventilatory acclimatization responders.  (A) 
Steady-state chemoreflex drive (SS-CD) hysteresis during ascent and descent of low responders. (B) 
SS-CD hysteresis during ascent and descent of high responders. (C) Comparison of SS-CD hysteresis 
area for low and high responders. (D) Comparison of the highest self-reported AMS score in low and 
high responders.  In A and B, grey circles denote ascent and white/clear squares denote descent. In 
C, SS-CD ascent-descent is presented in box and whisker format and compared between low (grey) 
and high (white/clear) responders. In D, the highest self-reported AMS score is compared between 
low (grey) and high (white/clear) responders, presented in box and whisker format.  *** = P<0.001 









Figure 5. Relationship between steady-state chemoreflex drive (SS-CD) hysteresis area and AMS 
symptom severity. (A) Correlation between SS-CD AUC and highest AMS score during ascent. (B) 
Comparison of SS-CD AUC between AMS positive (highest score 3+; n=11) and AMS negative (highest 
score 0-2; n=13) participants (p = 0.052).  
 
 
